Uji Efektivitas Antibiotik Cyprofloxacin, Enrofloxacin, Oxytetracycline Untuk Menghambat Bakteri Patogen Aeromonas Hydrophila Secara In Vitro Dan In Vivo

Dian Eka Ramadhan, M Isya Rais Ansori, Moch Rega Maulana, Meisya Meliana Putri, Anisa Anisa, Ridho Juliansyah, Risma Rosyada Juliani, Ghaida Refiana Zahra, Resti Dwi Anjani, Muhammad Lutfi Hauzan Tama, Athaya Maula, Sarah Sabilla Fauziah, Muhamad Erlan Hafid Djunaedi, Nazla Wafi Nurrafa, Mohamad Iqbal Kurniawinata

Abstract


Penelitian ini bertujuan untuk memperoleh jenis antibiotik dan dosis terbaik dalam menghambat bakteri patogen Aeromonas hydrophila (AHA). Penelitian dilakukan di Laboratorium Kesehatan dan Lingkungan Program Studi Teknologi dan Manajemen Pembenihan Ikan, Sekolah Vokasi IPB Sukabumi. Penelitian menggunakan metode tunggal dengan dua ulangan dan 10 perlakuan, yaitu: kontrol (K), P1 ciprofloxacin dosis 0,01 ppm, P2 ciprofloxacin dosis 0,02 ppm, P3 ciprofloxacin dosis 0,03 ppm, P4 enrofloxacin dosis 10 ppm, P5 enrofloxacin dosis 15 ppm, P6 enrofloxacin dosis 20 ppm, P7 oksitetrasiklin dosis 40 ppm, P8 oksitetrasiklin dosis 50 ppm, dan P9 oksitetrasiklin dosis 60 ppm. Pada metode kombinasi, digunakan dua ulangan dengan empat perlakuan, yaitu tiga perlakuan terbaik dari metode tunggal dan satu kontrol: K (kontrol), P1 ciprofloxacin dosis 3000 ppm + oksitetrasiklin dosis 60 ppm, P2 enrofloxacin dosis 10 ppm + ciprofloxacin dosis 0,003 ppm, dan P3 oksitetrasiklin dosis 60 ppm + enrofloxacin dosis 10 ppm. Sementara itu, pada metode ko-kultur digunakan dua ulangan dengan empat perlakuan, yaitu: P0 (kontrol/AHA), P2 enrofloxacin dosis 10 ppm, P3 ciprofloxacin dosis 3000 ppm, dan P4 oksitetrasiklin dosis 60 ppm. Parameter yang diamati meliputi zona hambat dan total jumlah bakteri patogen. Berdasarkan hasil penelitian, antibiotik ciprofloxacin pada dosis tunggal 0,003 ppm menunjukkan efektivitas paling tinggi terhadap bakteri patogen Aeromonas hydrophila, dengan zona hambat sebesar 18,4 mm. Pada metode kultur gabungan, ciprofloxacin juga terbukti paling efektif terhadap bakteri AHA, dengan hasil total plate count (TPC) terendah sebesar 5,7 × 10⁵ CFU/ml. Uji in vivo dengan ciprofloxacin dosis 3000 ppm menghasilkan tingkat kelangsungan hidup (SR) sebesar 55%.

This study aimed to determine the most effective type and dose of antibiotics to inhibit the pathogenic bacterium Aeromonas hydrophila. The research was conducted at the Health and Environmental Laboratory of the Fish Hatchery Technology and Management Study Program, IPB Sukabumi Vocational School. The study used a single-treatment method with two replications and ten treatments, namely: control (K), P1 ciprofloxacin at a dose of 0.01 ppm, P2 ciprofloxacin at 0.02 ppm, P3 ciprofloxacin at 0.03 ppm, P4 enrofloxacin at 10 ppm, P5 enrofloxacin at 15 ppm, P6 enrofloxacin at 20 ppm, P7 oxytetracycline at 40 ppm, P8 oxytetracycline at 50 ppm, and P9 oxytetracycline at 60 ppm. In the combination method, two replications were used with four treatments: three best treatments from the single method and one control, namely: K (control), P1 ciprofloxacin at 3000 ppm + oxytetracycline at 60 ppm, P2 enrofloxacin at 10 ppm + ciprofloxacin at 0.003 ppm, and P3 oxytetracycline at 60 ppm + enrofloxacin at 10 ppm. Meanwhile, in the coculture method, two replications and four treatments were applied: P0 (control/AHA), P2 enrofloxacin at 10 ppm, P3 ciprofloxacin at 3000 ppm, and P4 oxytetracycline at 60 ppm. The observed parameters included the inhibition zone and total pathogenic bacterial count. Based on the results, ciprofloxacin at a single dose of 0.003 ppm was the most effective against Aeromonas hydrophila, with an inhibition zone of 18.4 mm. In the combination culture method, ciprofloxacin also proved to be the most effective against AHA bacteria, with the lowest total plate count (TPC) result of 5.7 × 10⁵ CFU/ml. The in vivo test using ciprofloxacin at a dose of 3000 ppm resulted in a survival rate (SR) of 55%.


Keywords


Aeromonas hydrophila; ciprofloxacin; in vitro; in vivo

Full Text:

PDF

References


Ayunin, Q., Kartikaningsih, H., Andayani, S., Surantika, M., Fariedah, Fani, Soeprijanto, A., & Nasrullah, A. B. (2019). Efikasi oxytetracycline terhadap kesehatan ikan lele yang diinfeksi bakteri Edwardsiella tarda. JFMR-Journal of Fisheries and Marine Research, 3(1), 105-110.

Bojarski, B., Kot, B., & Witeska, M. (2020). Antibacterials in aquatic environment and their toxicity to fish. Pharmaceuticals, 13(8), 189.

Citarasu, T. (2010). Herbal biomedicines: A new opportunity for aquaculture industry. Aquaculture International, 18(3), 403–414.

Hameed, A. S. S., Rahaman, K. H., Alagan, A., & Yoganandhan, K. (2003). Antibiotic resistance in bacteria isolated from hatcheryreared larvae and post-larvae of Macrobrachium rosenbergii. Aquaculture, 217(1–4), 39–48.

Haque, M. R., Das, D. R., Sarkar, M. R., Begum, N., Pandit, D., & Jaman, A. (2023). Effect of stocking densities on growth and production performance of Bheda (Nandus nandus) in pond aquaculture. Aquatic Sciences and Engineering, 38(2), 97–105.

Heuer, O. E., Kruse, H., Grave, K., Collignon, P., Karunasagar, I., & Angulo, F. J. (2009). Human health consequences of use of antimicrobial agents in aquaculture. Clinical Infectious Diseases, 49(8), 1248–1253.

Hooper, D. C., & Jacoby, G. A. (2015). Mechanisms of drug resistance: Quinolone resistance. Annals of the New York Academy of Sciences, 1354(1), 12–31.

Indrawati, Y. (2016). Perbedaan daya antibakteri fraksi n-heksana jintan hitam (Nigella sativa) dengan cyprofloxacin terhadap methicillin resistant Staphylococcus aureus (MRSA) hasil isolat abses odontogenic [Unpublished undergraduate thesis]. Universitas Padjadjaran.

Islam, M., Khanom, H., Islam, N., Fariha, F., Paray, B. A., Zhangir, M. M., & Shajadhan, M. (2025). Probiotics and Spirulina platensis improved growth performance of Nile tilapia (Oreochromis niloticus) by upgrading intestinal morphology and activating GH/IGF axis. Aquaculture Research, 56(3), 123–135.

Jawetz, E., Melnick, J. L., & Adelberg, E. A. (2001). Medical microbiology (20th ed.). McGraw-Hill.

Kementerian Kelautan dan Perikanan Republik Indonesia. (2014). Keputusan Menteri Kelautan dan Perikanan Republik Indonesia Nomor 52/KEPMEN-KP/2014 tentang obat ikan yang diperbolehkan dan dilarang untuk digunakan di bidang budidaya ikan. Kementerian Kelautan dan Perikanan Republik Indonesia.

Mufidah, T. (2023). Efikasi dan farmakokinetik antibiotik untuk pengobatan infeksi Aeromonas hydrophila pada ikan lele (Clarias gariepinus) [Doctoral dissertation, Institut Pertanian Bogor]. IPB Repository.

Rico, A., Phu, T. M., Satapornvanit, K., Min, J., Shahabuddin, A. M., Henriksson, P. J. G., Murray, F. J., Little, D. C., Dalsgaard, A., & Van den Brink, P. J. (2013). Use of veterinary medicines, feed additives and probiotics in four major internationally traded aquaculture species. Aquaculture, 412–413, 231–243.

Romero, J., Feijoó, C. G., & Navarrete, P. (2012). Antibiotics in aquaculture—Use, abuse and alternatives. In E. Carvalho (Ed.), Health and environment in aquaculture (pp. 159–198). IntechOpen.

Saleh, A., Elkenany, R., & Younis, G. (2021). Virulent and multiple antimicrobial resistance Aeromonas hydrophila isolated from diseased Nile tilapia fish (Oreochromis niloticus) in Egypt with sequencing of some virulence-associated genes. Biocontrol Science, 26(3), 167–176.

Tjay, T. H., & Raharja, K. (2015). Obat-obat penting (7th ed.). PT Elex Media Komputindo.

Yanti, N.N., Prayitno, S.B., Sarjito. (2015). Patogenisitas dan sensitivitas agensia penyebab penyakit bakterial pada ikan gurami (Osphronemus Gouramy) terhadap berbagai macam obat beredar. Journal of Aquaculture Management and Technolog, 4(1),75-83.




DOI: http://dx.doi.org/10.15578/jmtr.v4i1.15149

Refbacks

  • There are currently no refbacks.


Pusat Penelitian dan Pengabdian kepada Masyarakat

Politeknik Kelautan dan Perikanan Kupang

Jl. Kampung Baru, Pelabuhan Ferry Bolok, Kecamatan Kupang Barat, Kabupaten Kupang, Nusa Tenggara Timur, 85351

P-ISSN: 29862310 

E-ISSN: 29860903 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

View My Stats